BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Nxera Pharma’s Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia

  May 1, 2025

   · 

  7 min read
• Press Releases

  Enara Bio Strengthens Senior Leadership with Key Executive and Board Appointments Alongside Acceleration of Multiple T-Cell Engager Programs

  May 1, 2025

   · 

  4 min read
• Press Releases

  Blue Earth Therapeutics initiates Phase 2 Clinical Trial evaluating the efficacy and safety of Lutetium (177Lu) rhPSMA-10.1 Injection in metastatic castrate resistant prostate cancer

  May 1, 2025

   · 

  5 min read
• Press Releases

  X4 Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates

  May 1, 2025

   · 

  15 min read
• Press Releases

  Biosplice Announces First Patient Dosed in Phase 2 Trial of Cirtuvivint for Advanced Soft-Tissue Sarcomas

  May 1, 2025

   · 

  4 min read
• Press Releases

  EnChannel Medical Raises $82.2M in Oversubscribed Series-B Financing to Advance Full-Chamber 5D Atrial Fibrillation Mapping and Personalized Pulsed-Field Ablation Therapy

  May 1, 2025

   · 

  2 min read
• Press Releases

  Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights

  May 1, 2025

   · 

  11 min read
• Press Releases

  BD Reports Second Quarter Fiscal 2025 Financial Results

  May 1, 2025

   · 

  39 min read
• Press Releases

  Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025

  May 1, 2025

   · 

  1 min read
• Press Releases

  IDEX Reports First Quarter Results

  May 1, 2025

   · 

  19 min read